SUBSCRIBE
SUBSCRIBE
News   Business

Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals Incorporated’s Board of Directors

July 8, 2009 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that Jeffrey Leiden, M.D., Ph.D. and Dennis Winger joined its board of directors.
People
Vertex Pharmaceuticals
MORE ON THIS TOPIC
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
3D illustration of hair root growing from skin cells, symbolizing strength, growth, and nourishment. Perfect for haircare, cosmetic advertising, medical research, and healthcare concepts.
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing three businesspeople hanging on the edge of a cliff
Layoffs
Q3 Layoffs Up 280% YOY With CSL, Merck, Novo’s Restructurings
October 16, 2025
 · 
4 min read
 · 
Angela Gabriel